Category: Uncategorized
Roche reports very strong sales growth in the first nine months of 2019 – outlook raised
Basel, 16 October 2019 Roche reports very strong sales growth in the first nine months of 2019 – outlook raised Group sales increase 10%1 at constant exchange rates and 9% in Swiss francs, due to new products Pharmaceuticals Division sales up 12%, driven by high demand for recently launched medicines, mainly Ocrevus, Hemlibra, Tecentriq and... Read more
Growth Strategy for Analytical & Measuring Instruments Business
Growth Strategy for Analytical & Measuring Instruments Business Read more
QIAGEN reports preliminary Q3 2019 results and announces measures to prioritize resource allocation
Preliminary Q3 2019 sales of about 3% CER growth (vs.~4-5% CER outlook), adjusted EPS in line with outlook Initiatives announced to free up resources to invest in best growth opportunities, in particular new partnership with Illumina in NGS clinical decision-making Venlo, The Netherlands, October 7, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today... Read more
Ad-hoc Announcement pursuant to Article 17 Market Abuse Regulation (3)
Venlo, The Netherlands, October 07, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announces preliminary sales results for the third quarter of 2019 fall short of expectations. For the third quarter of 2019, QIAGEN currently expects preliminary total net sales growth of about 3% at constant exchange rates (CER) compared to the... Read more
Ad-hoc Announcement pursuant to Article 17 Market Abuse Regulation (2)
Venlo, The Netherlands, October 7, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announces that Peer M. Schatz, Chief Executive Officer, has notified the Company that he has decided to step down as Chief Executive Officer and Chairman of the Management Board. He will remain with QIAGEN as Advisor to the Supervisory Board... Read more
Ad-hoc Announcement pursuant to Article 17 Market Abuse Regulation
Venlo, The Netherlands, October 7, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announces measures to prioritize resource allocation to the most attractive growth opportunities in its Sample to Insight portfolio, in particular in light of a new orientation for its next-generation sequencing (NGS) activities. The measures to free up resources comes... Read more
Roche's Tecentriq improves overall survival as a first-line monotherapy in certain people with advanced non-small cell lung cancer
Basel, 27 September 2019 Roche’s Tecentriq improves overall survival as a first-line monotherapy in certain people with advanced non-small cell lung cancer Phase III IMpower110 study showed Tecentriq monotherapy helped people with advanced non-small cell lung cancer (NSCLC) with high PD-L1 expression live longer compared with chemotherapy alone Data will be shared with health authorities... Read more
Luminex Corporation to Present at the Cantor Global Healthcare Conference on October 2, 2019
AUSTIN, Texas, Sept. 26, 2019 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that Homi Shamir, President and Chief Executive Officer, and Harriss Currie, Senior Vice President of Finance and CFO, will participate in investor meetings and present at the Cantor Global Healthcare Conference on Wednesday, October 2, 2019 in New York, NY. A live... Read more
Nalgene Outdoor Applauds Quick-Thinking of Hikers and Rescuers in “Message in a Bottle” Rescue
Nalgene Outdoor Applauds Quick-Thinking of Hikers and Rescuers in “Message in a Bottle” Rescue ROCHESTER, N.Y., Sept. 13, 2019 /PRNewswire/ — Nalgene Outdoor, manufacturers of the original water bottle that traces its roots back to 1949, applauds the search and rescue workers and quick-thinking of Curtis Whitson who used an SOS message in a Nalgene... Read more